Media critic Jack Shafer on Slate.com writes about, “A Midsummer’s Stew of Bogus Trends: Robo tripping, digital drugs, temporary dropouts, and subway hogs.” Excerpt:
” “[T]here is much to be said in favour of modern journalism,” Oscar Wilde once wrote. “By giving us the opinions of the uneducated, it keeps us in touch with the ignorance of the community.”
I think of Wilde’s words every time I carve a column out of the bogus trend story nominees submitted almost daily by readers and friends. The bogus trend story inflates the specific into the general, frightens the timid, exploits the guileless, and insults the intelligence of the wise. It is the journalism of grunts and moans, of unchecked stupidity and laziness, and wherever it appears it shrinks the collective IQ.
The leading offender in today’s column is an item on the blog of CNN’s Sanjay Gupta. The piece, “Parents Be Warned: Your Kids May Be ‘Robo Tripping,’ ” (July 8) warns that there’s a drug trend among kids called “Robo tripping,” in which they consume great quantities of dextromethorphan–an active agent in some cough syrups.”
Read more about Shafer’s criticism of Gupta and of other trends reported by following the link above.
Being wrong is getting a lot of attention lately.
Joe McCarthy, on his Gumption blog, had a fantastic summary of stuff he’s seen under the umbrella of “wrongology” – “All models, studies and Wikipedia entries are wrong, some are useful.” In this piece, he cites Kathryn Schulz (author of “Being Wrong”), Kent Bottles, another Sanjay Gupta story (that I had written about), Susannah Fox, Gilles Frydman, and W. Joseph Campbell’s terrific book, “Getting it Wrong: Ten of the Greatest Misreported Stories in American Journalism.”
Read the entire Gumption piece. It’s a gold mine of wrongology.
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like